[ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿Çâ ] 2020³â 12¿ù ¿¬±¸µ¿Çâ : Å°¿öµå Ŭ¶ó¿ìµå ³×Æ®¿öÅ© ºÐ¼®
ÀÇ»ý¸íºÐ¾ß ³í¹®µ¥ÀÌÅ͸¦ ºÐ¾ßº°·Î ÀÓ»óÀÇÇÐ, ±âÃÊÀÇÇÐ, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ, °£È£ÇÐ, Ä¡ÀÇÇÐ Àú³Î¿¡¼ 2020³â 12¿ù¿¡ ÇÑ´Þµ¿¾È ¹ßÇ¥µÈ ³í¹® µ¥ÀÌÅ͸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ý¸íºÐ¾ß¸¦ ÅëÇÕÇÏ¿© 12¿ù ¿¬±¸µ¿Çâ Å°¿öµåºÐ¼®À» ¼öÇàÇÏ¿´À½. ÀÚ·á´Â Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ ±¹³»¿Í ±¹¿Ü¿¡ ¹ßÇ¥ÇÑ ÀÇÇÐ³í¹® µ¥ÀÌÅͺ£À̽ºÀÎ Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º (KMbase)¿Í Çѱ¹ÀÎ ÀúÀÚ°¡ ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ PubMed DB¿¡ À妽ºµÈ ³í¹®µ¥ÀÌÅ͸¦ ÃßÃ⠺м®ÇÔ.
12¿ù ÀÓ»óÀÇÇÐ, ±âÃÊÀÇÇÐ, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ, °£È£ÇÐ, Ä¡ÀÇÇко߸¦ ÅëÇÕÇÏ¿© ºÐ¼®ÇÑ Àüü ÀÇ°úÇÐºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå´Â Risk (À§Çè), Genes (À¯ÀüÀÚ), Women (¿©¼º), Neoplasms (½Å»ý¹°), General Surgery (¼ö¼ú), Role (¿ªÇÒ), Attention (ÁÖÀÇ), COVID-19 (Äڷγª-19), Drug (¾à¹°), Complication (ÇÕº´Áõ), Mortality (»ç¸Á·ü), Economics (°æÁ¦ÇÐ), Survival Rate (»ýÁ¸À²), Sensitivity & Specificity (¹Î°¨µµ¿Í ƯÀ̵µ), Pain (ÅëÁõ), Liver (°£) µîÀÌ »óÀ§ Å°¿öµå·Î ³ªÅ¸³².
ÀÌ´Â Àü¿ù Å°¿öµåÀÎ Risk (À§Çè), Genes (À¯ÀüÀÚ), Neoplasms (Á¾¾ç), Attention (ÁÖÀÇ), General Surgery (¼ö¼ú), Role (¿ªÇÒ), Survival Rate (»ýÁ¸À²), Drug (¾à¹°), Sensitivity & Specificity (¹Î°¨µµ ƯÀ̵µ), Complication (ÇÕº´Áõ), Mortality (»ç¸ÁÀ²), Economics (°æÁ¦), Depression (¿ì¿ï), COVID-19 (Äڷγª19), Pain (ÅëÁõ), Brain (³ú) Å°¿öµå¿Í ¸Å¿ì À¯»çÇÑ ¾ç»óÀ¸·Î ºÐ¼®µÇ¾úÀ½.
Áö¼ÓÀûÀ¸·Î »óÀ§ ÃâÇö Å°¿öµå´Â À¯ÀüÀÚ(Genes), Á¾¾ç(Neoplasms), ÁÖÀÇ(Attention), ¿ªÇÒ(Role), ¼ö¼ú(General Surgery), Äڷγª19( COVID-19), °æÁ¦¼º(Economics), ÇÕº´Áõ(Complication) »ýÁ¸À²(Survival Rate), Mortality (»ç¸Á·ü), ¹Î°¨µµ¿Í ƯÀ̵µ(Sensitivity & Specificity), ¾à¹°(Drug), ÅëÁõ(Pain) µîÀÇ ¿¬±¸ Å°¿öµå´Â ²ÙÁØÈ÷ »óÀ§·Î ÃâÇöÇÏ¿´À¸¸ç Äڷγª-19¿Í °ü·ÃµÈ Å°¿öµåÀÎ COVID-19, Complication (ÇÕº´Áõ), »ýÁ¸À²(Survival Rate), Mortality (»ç¸Á·ü), ¹Î°¨µµ¿Í ƯÀ̵µ(Sensitivity & Specificity), ¾à¹°(Drug), Economics (°æÁ¦) µîÀÌ Áö¼ÓÀûÀ¸·Î »óÀ§·Î ³ªÅ¸³².
±×¸² 1. Çѱ¹ÀÇ°úÇÐ ¿¬±¸µ¿ÇâºÐ¼® : 2020³â 12¿ù ÇÙ½É Å°¿öµå Ŭ¶ó¿ìµå
ÀÇ°úÇÐºÐ¾ß ÅäÇÈ ¸ðµ¨¸µºÐ¼® ÁÖÁ¦Å½»ö ¾Ë°í¸®ÁòÀ» ÅëÇØ Áß¿ä´Ü¾îµéÀÇ ³×Æ®¿öÅ©¸¦ ÃßÃâÇÑ °á°ú´Â Ç¥ 1°ú, ±×¸² 2¿¡ Á¦½ÃµÈ ¹Ù¿Í °°ÀÌ Risk (À§Çè), Genes (À¯ÀüÀÚ), COVID-19 (Äڷγª-19) µîÀÇ ÅäÇÈ ¿öµå¸¦ Áß½ÉÀ¸·Î ¿¬±¸µ¿Çâ ³×Æ®¿öÅ©¸¦ Çü¼ºÇÏ°í ÀÖÀ½.
±×¸² 2. ÀÇ°úÇÐºÐ¾ß 12¿ù ¿¬±¸ÁÖÁ¦Å½»ö ¾Ë°í¸®Áò°ú ÁÖ¿ä Å°¿öµå ³×Æ®¿öÅ© Çü¼º
Ç¥ 1. ÀÇ°úÇÐ 12¿ù ÅäÇÈ ¸ðµ¨¸µ(ÅäÇȴܾî ÃßÃâ) ¹× ³×Æ®¿öÅ© µ¿Çâ
Topic1
|
Topic2
|
Topic3
|
Topic4
|
Topic5
|
COVID-19
|
Risk
|
Risk
|
Genes
|
Sensitivity & Specificity
|
Water
|
Mortality
|
Depression
|
Economics
|
Bone And Bones
|
Attention
|
Neoplasm Metastasis
|
Women
|
In Vitro Techniques
|
General Surgery
|
Efficiency
|
Neoplasms
|
Population
|
Role
|
Pain
|
Anti-Bacterial Agents
|
Survival Rate
|
Diabetes
|
Humans
|
F-18 Fdg Pet
|
Soil
|
Death
|
Adult
|
Neoplasms
|
Liver
|
Environment
|
Exercise
|
Pediatrics
|
Apoptosis
|
Complication
|
Stability
|
Stroke
|
Bmi
|
DNA
|
Kidney
|
Economics
|
Recurrence
|
Sex
|
Brain
|
Fibrosis
|
Role
|
General Surgery
|
Older Adults
|
RNA
|
Hip
|
Ç¥ 2. ÀÇ°úÇÐ ÃֽŠ¿¬±¸µ¿Ç⠺м® : 2020³â 12¿ù Å°¿öµå ºóµµºÐ¼®( N=3,412)
¼øÀ§
|
±¹³» Àú³Î
ÀÇ°úÇÐ »óÀ§Å°¿öµå
|
±¹¿Ü Àú³Î
ÀÇ°úÇÐ »óÀ§Å°¿öµå
|
ÀÇ°úÇÐ ÅëÇÕ
¿¬±¸µ¿Çâ Å°¿öµå
|
1
|
General Surgery
|
Risk
|
General Surgery
|
2
|
Complication
|
Genes
|
Risk
|
3
|
Women
|
Neoplasms
|
Women
|
4
|
Pediatrics
|
Attention
|
COVID-19
|
5
|
Risk
|
Women
|
Pediatrics
|
6
|
Neoplasms
|
Role
|
Complication
|
7
|
Pain
|
Survival Rate
|
Genes
|
8
|
Education
|
Humans
|
Older Adults
|
9
|
Depression
|
Economics
|
Neoplasms
|
10
|
Adult
|
Sensitivity And Specificity
|
Role
|
11
|
COVID-19
|
Drug
|
Pain
|
12
|
Recurrence
|
General Surgery
|
Mortality
|
13
|
Genes
|
Mortality
|
Adult
|
14
|
Attention
|
Population
|
Drug
|
15
|
Humans
|
Adult
|
Liver
|
16
|
Drug
|
Brain
|
Education
|
17
|
Evaluation Studies As Topic
|
COVID-19
|
Death
|
18
|
Behavior
|
Complication
|
Recurrence
|
19
|
Bone And Bones
|
Pain
|
Population
|
20
|
Anxiety
|
Serum
|
Economics
|
2020³â ÇϹݱâ 6¿ùºÎÅÍ 12¿ù±îÁö ÀÇ°úÇÐºÐ¾ß ÇϹݱ⠿¬±¸¹ßÇ¥ °æÇâÀ» ºÐ¼®Çϸé ÃÑ 27,648ÆíÀ¸·Î ¿ù Æò±Õ 4,608ÆíÀ¸·Î ³ªÅ¸³²(±×¸² 3).
±×¸² 3) 2020³â ÇϹݱâ ÀÇ°úÇÐºÐ¾ß ¿¬±¸¹ßÇ¥ °æÇâ
±×¸² 4) 2020³â 12¿ù ÃֽŠÀÇ°úÇÐ ºÐ¾ßº° ³í¹®¹ßÇ¥ °æÇâ
ÀÇ°úÇÐºÐ¾ß ÃֽŠ12¿ù¿¡ ±¹³»Àú³Î°ú ±¹¿Ü Àú³ÎÀ» ÅëÇØ ¹ßÇ¥µÈ ÀÇ°úÇÐºÐ¾ß Àüü ³í¹®Àº 3,412ÆíÀ¸·Î 11¿ù 3,820Æí°ú ºñ±³ÇÏ¿© ´Ù¼Ò °¨¼ÒÇÑ Ãß¼¼¸¦ ³ªÅ¸³¿. ºÐ¾ßº°·Î´Â ÀÓ»óÀÇÇÐ 1,681Æí, ±âÃÊÀÇÇÐ 1,164Æí, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ 344Æí, °£È£ÇÐ 120Æí, Ä¡ÀÇÇÐ 103Æí ¼øÀ¸·Î ³ªÅ¸³µÀ¸¸ç, ÀÓ»óÀÇÇаú ±âÃÊÀÇÇÐ ºÐ¾ß°¡ Â÷ÁöÇÏ´Â ºñÀ²Àº Àüü ÀÇ°úÇÐ ºÐ¾ß Áß¿¡¼ 83.4%¸¦ Â÷ÁöÇÏ¿´À½.
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC)